Genprex Statistics
Total Valuation
Genprex has a market cap or net worth of $5.24 million. The enterprise value is -$12.81 million.
| Market Cap | 5.24M |
| Enterprise Value | -12.81M |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Genprex has 10.59 million shares outstanding. The number of shares has increased by 1,648.49% in one year.
| Current Share Class | 10.59M |
| Shares Outstanding | 10.59M |
| Shares Change (YoY) | +1,648.49% |
| Shares Change (QoQ) | +229.76% |
| Owned by Insiders (%) | 0.21% |
| Owned by Institutions (%) | 1.29% |
| Float | 10.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.26 |
| P/TBV Ratio | 0.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.61
| Current Ratio | 5.61 |
| Quick Ratio | 5.38 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -21.68 |
Financial Efficiency
Return on equity (ROE) is -160.84% and return on invested capital (ROIC) is -96.41%.
| Return on Equity (ROE) | -160.84% |
| Return on Assets (ROA) | -76.19% |
| Return on Invested Capital (ROIC) | -96.41% |
| Return on Capital Employed (ROCE) | -94.62% |
| Weighted Average Cost of Capital (WACC) | -1.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.29M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.62% in the last 52 weeks. The beta is -0.96, so Genprex's price volatility has been lower than the market average.
| Beta (5Y) | -0.96 |
| 52-Week Price Change | -95.62% |
| 50-Day Moving Average | 0.79 |
| 200-Day Moving Average | 3.83 |
| Relative Strength Index (RSI) | 33.80 |
| Average Volume (20 Days) | 394,838 |
Short Selling Information
The latest short interest is 976,021, so 9.22% of the outstanding shares have been sold short.
| Short Interest | 976,021 |
| Short Previous Month | 1.03M |
| Short % of Shares Out | 9.22% |
| Short % of Float | 9.24% |
| Short Ratio (days to cover) | 2.66 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.04M |
| Pretax Income | -16.73M |
| Net Income | -16.73M |
| EBITDA | n/a |
| EBIT | -16.04M |
| Earnings Per Share (EPS) | -$6.45 |
Balance Sheet
The company has $18.05 million in cash and n/a in debt, with a net cash position of $18.05 million or $1.70 per share.
| Cash & Cash Equivalents | 18.05M |
| Total Debt | n/a |
| Net Cash | 18.05M |
| Net Cash Per Share | $1.70 |
| Equity (Book Value) | 16.93M |
| Book Value Per Share | 1.87 |
| Working Capital | 15.45M |
Cash Flow
| Operating Cash Flow | -14.29M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -14.29M |
| FCF Per Share | -$1.35 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Genprex does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,648.49% |
| Shareholder Yield | -1,648.49% |
| Earnings Yield | -319.32% |
| FCF Yield | -272.77% |
Analyst Forecast
The average price target for Genprex is $375.00, which is 75,688.20% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $375.00 |
| Price Target Difference | 75,688.20% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 21, 2025. It was a reverse split with a ratio of 1:50.
| Last Split Date | Oct 21, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |